Central Trust Company’s Globus Medical GMED Stock Holding History

Central Trust Company’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.38K	Sell	106 -53	-33%	-$4.5K	﹤0.01%	1250
2026 Q1	$13.7K	Buy	159 +4	+3%	+$359	﹤0.01%	1090
2025 Q4	$13.5K	Sell	155 -150	-49%	-$11.4K	﹤0.01%	1069
2025 Q3	$17.5K	Sell	305 -361	-54%	-$20.8K	﹤0.01%	1013
2025 Q2	$39.3K	Buy	+666	New	+$43K	﹤0.01%	849
2018 Q4	–	Sell	-230	Closed	-$13K	–	1189
2018 Q3	$13K	Hold	230	–	–	﹤0.01%	929
2018 Q2	$12K	Buy	+230	New	+$12K	﹤0.01%	937
2016 Q3	–	Sell	-1,979	Closed	-$47K	–	1131
2016 Q2	$47K	Hold	1,979	–	–	﹤0.01%	689
2016 Q1	$47K	Buy	1,979 +356	+22%	+$8.7K	﹤0.01%	692
2015 Q4	$45K	Buy	1,623 +729	+82%	+$18.3K	﹤0.01%	668
2015 Q3	$18K	Buy	894 +327	+58%	+$8.28K	﹤0.01%	860
2015 Q2	$15K	Sell	567 -56	-9%	-$1.42K	﹤0.01%	921
2015 Q1	$16K	Hold	623	–	–	﹤0.01%	887
2014 Q4	$15K	Sell	623 -47	-7%	-$1.04K	﹤0.01%	899
2014 Q3	$13K	Buy	+670	New	+$13.8K	﹤0.01%	936

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Central Trust Company's GMED Position: Q2 2026 in Review

Central Trust Company reduced its Globus Medical (GMED) stake by 33% in Q2 2026, selling an estimated $4.5K and leaving 106 shares worth $8.38K. The position accounts for ﹤0.01% of the portfolio, ranked #1250.

Central Trust Company first reported a position in GMED in Q3 2014 and has held it in 15 quarters since. The position peaked at $47K in Q2 2016. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Central Trust Company held 106 shares of Globus Medical worth $8.38K as of Q2 2026.
Central Trust Company sold 53 Globus Medical shares in Q2 2026, an estimated $4.5K.
Globus Medical made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1250 holding.
Central Trust Company first reported a position in Globus Medical in Q3 2014 and has held it in 15 quarters since.
Central Trust Company's Globus Medical position peaked at $47K in Q2 2016.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.